Stem Cells, PRP and Exosomes for Androgenetic Alopecia in Cancún

Why androgenetic alopecia needs a biological answer

Androgenetic alopecia, also known as male or female pattern hair loss, is the most common cause of progressive hair thinning worldwide. It affects an estimated 50% of men by age 50 and a significant proportion of women, particularly after menopause. The condition is driven by a combination of genetic susceptibility and the action of dihydrotestosterone (DHT) on hair follicles in genetically predisposed scalp regions. Over time, follicles undergo a process called miniaturization: the growth phase shortens, the hair shaft becomes thinner, and eventually the follicle stops producing visible hair.

For decades, treatment options were limited to topical minoxidil, oral finasteride, and hair transplantation. These remain valid first-line tools and continue to be the foundation of any serious treatment plan. What has changed in the last decade is the emergence of regenerative therapies, including platelet-rich plasma, mesenchymal stem cell preparations, and exosome-based protocols, that aim to act directly on the biology of the follicle. At Regeneris Therapy in Cancún, these treatments are offered as part of a structured, evidence-based plan rather than as standalone miracle cures. The first step is always a thorough medical evaluation to confirm the diagnosis and rule out other causes of hair loss.

PRP for androgenetic alopecia: the best-studied option

Platelet-rich plasma, or PRP, is currently the most studied regenerative therapy for androgenetic alopecia. The principle is the same as in other PRP applications: a small volume of the patient's blood is drawn, centrifuged to concentrate the platelets, and the resulting preparation is injected into the scalp at the level of the follicular bulge. The platelets release growth factors such as PDGF, VEGF, IGF-1, and TGF-β, which appear to prolong the anagen (growth) phase, support dermal papilla cells, and improve perifollicular vascularization.

Multiple randomized controlled trials and meta-analyses, including work published in journals such as *Dermatologic Surgery* and the *Journal of the American Academy of Dermatology*, have reported improvements in hair density and shaft caliber in patients with early to moderate androgenetic alopecia. The effect sizes are modest but consistent across studies that use standardized protocols. Reported benefits typically include an increase of 15 to 30 hairs per square centimeter and a measurable improvement in hair caliber after a series of three to four sessions spaced four to six weeks apart, followed by maintenance every six to twelve months.

PRP is not a cure. It does not stop the underlying genetic and hormonal process driving miniaturization, which means results are gradual and require maintenance. It also does not regrow hair in areas where follicles have already disappeared. Its place in the protocol is to support existing follicles that are thinning but still alive, ideally in patients who are also using minoxidil and, when appropriate, finasteride or dutasteride. You can read more about how PRP works in our complete guide to platelet-rich plasma therapy.

Stem cells for hair loss: what the evidence actually shows

The phrase "stem cells for hair loss" is used loosely in the aesthetic market, and patients deserve a clear explanation of what is and is not supported by evidence. In clinical practice, what is usually offered under this label is a preparation derived from mesenchymal stem cells (MSCs), most often from adipose tissue or umbilical cord, or a concentrate of stromal vascular fraction (SVF) obtained from a small liposuction. These preparations are rich in MSCs, pericytes, and secreted factors that have shown the ability to modulate inflammation and support tissue regeneration in laboratory and early clinical studies.

In the context of androgenetic alopecia, the rationale is that MSC-derived factors may protect hair follicle stem cells in the bulge region, stimulate dermal papilla activity, and improve the local microenvironment around miniaturized follicles. Early clinical trials and case series, including studies on adipose-derived stem cell preparations and conditioned media, have reported improvements in hair count and density. However, the overall body of evidence remains smaller and more heterogeneous than for PRP. Protocols vary widely, and direct head-to-head comparisons are still limited.

It is also important to distinguish between true cell therapy, where viable MSCs are isolated and administered, and acellular preparations derived from stem cell culture, such as conditioned media or exosomes. The two are biologically different and should not be marketed interchangeably. At Regeneris, any stem cell-based protocol is performed under proper medical indication, with full transparency about the source of the cells, the laboratory standards involved, and the regulatory framework. Mexico's Federal Commission for the Protection against Sanitary Risk (COFEPRIS) regulates the use of cellular therapies, and a serious clinic will operate within this framework rather than around it.

Exosomes for hair restoration: the newest tool

Exosomes are small extracellular vesicles, typically 30 to 150 nanometers in diameter, released by cells as part of normal intercellular communication. They carry proteins, lipids, messenger RNA, and microRNAs that can influence the behavior of recipient cells. In regenerative medicine, exosomes derived from MSCs are of particular interest because they appear to reproduce many of the paracrine effects of the parent cells without containing the cells themselves. This makes them easier to standardize, store, and apply.

For androgenetic alopecia, exosome preparations are typically applied to the scalp through microneedling or fine intradermal injections, often in combination with PRP. Early studies and clinical reports, including work presented at international dermatology and hair restoration meetings, suggest that exosome-based protocols may increase hair density, accelerate the transition of follicles into the anagen phase, and improve the perifollicular environment. Patients often report noticeable changes in hair quality within three to four months, with peak effects between six and nine months after a series of treatments.

The honest caveat is that exosome therapy for hair is still a relatively young field. The product landscape is heterogeneous, and not all exosome preparations are equivalent in quality, concentration, or characterization. A responsible clinic will tell you the source of the exosomes, the manufacturing standards, and the limitations of the current evidence. Marketing claims that promise dense regrowth in bald areas should be regarded with skepticism. For a deeper comparison between cell-based and vesicle-based approaches, our article on exosomes vs stem cells provides additional context.

PRP vs stem cells vs exosomes: how to think about the choice

Patients searching for regenerative hair therapy in Cancún often arrive with the question, "Which one is best?" The honest answer is that the three therapies are not direct competitors. They occupy different positions on a spectrum and are often combined.

• PRP is the most accessible, the best studied, and the most cost-effective. It is autologous, has a strong safety profile, and is supported by the largest body of clinical evidence. It is usually the first regenerative step in early to moderate androgenetic alopecia.
• Stem cell preparations, when delivered under proper medical and regulatory standards, offer a more potent biological signal. They may be considered in patients with more advanced thinning who still have viable follicles, or in those who have not responded adequately to PRP and standard medical therapy.
• Exosomes are an attractive complement because they are acellular, easier to standardize, and can be combined with PRP or microneedling. They are particularly interesting in patients who want to enhance the response to other treatments or who are looking for a non-cellular regenerative option.

The decision is clinical, not commercial. It depends on the stage of hair loss, the patient's age and overall health, prior treatments, expectations, and budget. A protocol that combines minoxidil, finasteride or dutasteride when appropriate, PRP as a base regenerative layer, and exosomes or stem cell-derived factors as a booster tends to outperform any single intervention used in isolation.

Ideal candidates vs hair transplant cases

Regenerative therapies and hair transplantation are not mutually exclusive; they address different problems. Knowing where each one fits is essential.

Ideal candidates for regenerative therapy include patients with:

• Early to moderate androgenetic alopecia, typically Norwood II to V in men and Ludwig I to II in women.
• Diffuse thinning where follicles are miniaturized but still present.
• Postpartum or stress-related telogen effluvium on top of a genetic predisposition.
• Patients who want to preserve and strengthen existing hair before considering surgery.
• Patients who have undergone a hair transplant and want to protect the surrounding native hair and support graft survival.

Hair transplantation, on the other hand, is the appropriate solution when follicles in the affected area are no longer present. No regenerative therapy can regrow hair from scar tissue or from areas where the follicle has completely disappeared. In these cases, surgical techniques such as FUE remain the only effective option. Many patients benefit from a combined plan in which regenerative therapy is used to stabilize the rest of the scalp before and after transplantation, improving the overall density and quality of the final result.

A responsible consultation will tell you clearly whether you are a candidate for regenerative therapy, for surgery, or for both. You can learn more about how we approach this evaluation on our hair restoration page and explore the full list of conditions we treat at the clinic.

The Regeneris protocol in Cancún

At Regeneris Therapy, the hair restoration protocol is built around three principles: accurate diagnosis, layered therapy, and honest follow-up. The process begins with a detailed clinical history, scalp examination with trichoscopy, and basic laboratory work to rule out thyroid disease, iron deficiency, hormonal imbalances, and other contributors to hair loss. Photographic documentation in standardized lighting allows objective comparison over time.

Based on the findings, the medical team designs an individualized plan. For most patients with early to moderate androgenetic alopecia, the core protocol includes a series of three to four PRP sessions spaced four to six weeks apart, often combined with topical or microneedled exosome preparations. When indicated, stem cell-derived therapies are integrated under appropriate medical and regulatory criteria. Standard medical therapy with minoxidil and, in selected cases, oral antiandrogens, is discussed openly so patients understand the role of each component.

All procedures are performed by licensed physicians, with biologic products handled under controlled laboratory conditions and within the framework set by COFEPRIS. You can meet the physicians leading the protocol on our team page. For international patients, Cancún offers a unique combination of high-standard medical care, direct flights from most major North American cities, and a comfortable environment for recovery. Medical tourism to Cancún is not just about price; it is about accessing protocols that are sometimes more flexible and integrated than what is available in fragmented healthcare systems abroad.

Frequently asked questions

How long until I see results? Hair cycles are slow. Most patients begin to notice less shedding and improved hair quality within two to three months. Visible changes in density typically appear between four and six months, with continued improvement up to nine to twelve months after the initial series.

Is the treatment painful? Scalp injections can be uncomfortable. Topical anesthesia, cold air devices, and slow injection techniques are used to minimize discomfort. Most patients tolerate the sessions well and return to normal activities the same day.

Do I need to keep using minoxidil and finasteride? In most cases, yes. Regenerative therapies work best when combined with standard medical therapy that addresses the underlying hormonal driver of androgenetic alopecia. Stopping these medications can erase the gains achieved.

Is it safe to travel to Cancún for hair regrowth treatment in Mexico? Yes, when you choose a clinic that operates under proper medical and regulatory standards. Look for licensed physicians, transparent protocols, traceable biologic products, and clear follow-up. Avoid clinics that guarantee outcomes or promote stem cell or exosome therapy as a universal solution.

How do I know which therapy is right for me? Only a proper consultation can answer this. The right combination of PRP, stem cells, exosomes, and standard medical therapy depends on your specific pattern of hair loss, your medical history, and your goals. The team at Regeneris will review all of these factors and design a plan that is realistic, evidence-based, and tailored to your case.